Emerging research suggests a complex interaction between the gut microbiome and endometriosis. Recent studies have begun to explore the impact of dietary interventions on endometriosis.
Clinical translation of microbiome research: takeaways from the 2025 GMFH Summit
16 May 2025by Andreu Prados
The 13th Gut Microbiota for Health World Summit took place 15-16 March 2025 in Washington, D.C., and it focused on advances in microbiome research to diagnose, prevent, and manage gastrointestinal and extra-intestinal conditions. Find out more about the most valuable takeaways from the event.
Scientists uncover a new way by which gut microbes control cholesterol levels
24 Feb 2025by Mónica Quinzo
Gut microbiota aids in fat digestion by converting primary bile acids into unconjugated and secondary bile acids. Recent research in mice has uncovered an intricate host-microbiota partnership in regulating bile acid production, helping to prevent excessive accumulation and maintain metabolic balance.
Unlocking the diagnostic and therapeutic potential roles of gut microbiome: takeaways from the 2024 GMFH Summit
23 May 2024by Joël Doré, Andreu Prados
The last 12th Gut Microbiota for Health World Summit took place 23-24 March 2024 in Washington, D.C. and focused on relevant gut microbiome advances from the lab to the clinic. Find out more about the main takeaways of the conference and how they might affect your research and practice.
Dysosmobacter welbionis as potential promising next-generation probiotic for improving metabolic health?
8 May 2024by Patrice D. Cani
Dysosmobacter welbionis is a typical inhabitant of the human gut. New findings suggest it could be a potential next-generation beneficial bacterium for tackling specific cardiometabolic disorders linked to obesity and type 2 diabetes.
Patients with metabolic liver diseases may benefit from supplements of a common gut bacterium, a small study suggests.
Reduced red meat intake and gut microbial metabolite indole-3-acetate linked to better insulin resistance after gastric bypass, new study finds
8 Jan 2024by Joël Doré, Andreu Prados
The gut microbiome has been involved in reducing adiposity in patients with obesity after gastric bypass. New research suggests that food intake, tryptophan metabolism, and gut microbiota composition can explain the glycemic improvement observed in patients after Roux-en-Y gastric bypass.
Diagnosing IBS and targeting gut microbiota and metabolites to improve symptoms
18 Oct 2023by Andrea Costantino
Chronic abdominal pain, diarrhea, constipation, and bloating are common gastrointestinal symptoms. While a structural or an organic disease can be suspected because of the symptoms and is often easy to be diagnosed by endoscopy or imaging methods, sometimes gastrointestinal symptoms are not related to any alteration that may be seen through diagnostic techniques, and consequently have been classified under the umbrella of “disorders of gut-brain interaction”.
Are we ready to target the gut microbiota for obesity and weight management? A journey from bench to bedside
24 May 2023by Andreu Prados, Patrice D. Cani
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The translational potential of microbiome research for human health and disease: takeaways from the 2023 GMFH Summit
28 Apr 2023by Andreu Prados, Joël Doré
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.